|
|
|
501-1,000 employees
View all
|
|
biotechnology
|
|
Windrush Court,Oxford,Oxfordshire,GB
|
|
Oxford BioMedica (OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. We have built a sector-leading lentiviral vector delivery platform, called LentiVector®, which we use to develop in vivo and ex vivo products both in-house and with partners. We have created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. We also have a number of partnerships, including with Novartis, Sanofi, GSK and Orchard Therapeutics, where we have long-term economic interests in other potential gene and cell therapy products. OXB is based across four locations in Oxfordshire, UK.
|
Oxford Biomedica Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}.{last} | [email protected] |
100%
|
The widely used Oxford Biomedica email format is {f}.{last} (e.g. [email protected]) with 100% adoption across the company.
To contact Oxford Biomedica customer service number in your country click here to find.
Nicola Deeley is the CEO of Oxford Biomedica.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.